User profiles for Anu Jacob

ANU JACOB

Cleveland Clinic Abu Dhabi
Verified email at clevelandclinicabudhabi.ae
Cited by 17199

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

…, J De Seze, K Fujihara, B Greenberg, A Jacob… - Neurology, 2015 - AAN Enterprises
Neuromyelitis optica (NMO) is an inflammatory CNS syndrome distinct from multiple
sclerosis (MS) that is associated with serum aquaporin-4 immunoglobulin G antibodies (AQP4-IgG). …

Myelin-oligodendrocyte glycoprotein antibody-associated disease

…, K Deiva, J De Sèze, K Fujihara, A Jacob… - The Lancet …, 2021 - thelancet.com
Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently
identified autoimmune disorder that presents in both adults and children as CNS demyelination…

[HTML][HTML] MOG encephalomyelitis: international recommendations on diagnosis and antibody testing

…, J De Seze, D Franciotta, K Fujihara, A Jacob… - Journal of …, 2018 - Springer
Over the past few years, new-generation cell-based assays have demonstrated a robust
association of autoantibodies to full-length human myelin oligodendrocyte glycoprotein (MOG-…

Clinical presentation and prognosis in MOG-antibody disease: a UK study

…, G Reynolds, S Chandratre, C Hemingway, A Jacob… - Brain, 2017 - academic.oup.com
See de Seze (doi: 10.1093/brain/awx292 ) for a scientific commentary on this article. A condition
associated with an autoantibody against MOG has been recently recognized as a new …

MRI characteristics of neuromyelitis optica spectrum disorder: an international update

…, O Aktas, J Wuerfel, TJ Smith, N Asgari, A Jacob… - Neurology, 2015 - AAN Enterprises
Since its initial reports in the 19th century, neuromyelitis optica (NMO) had been thought to
involve only the optic nerves and spinal cord. However, the discovery of highly specific anti–…

Treatment of neuromyelitis optica with rituximab

A Jacob, BG Weinshenker, I Violich, N McLinskey… - Arch Neurol, 2008 - jamanetwork.com
Background: Neuromyelitis optica (NMO) is an uncommon, life-threatening inflammatory
demyelinating disorder. Recently, much has become known about its immunopathogenesis. …

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan

…, M Woodhall, J George, M Boggild, A Vincent, A Jacob… - Brain, 2012 - academic.oup.com
Neuromyelitis optica and neuromyelitis optica spectrum disorders have been recently
associated with the disease-specific autoantibody aquaporin-4, thought to be pathogenic. …

[HTML][HTML] Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide

…, SA Broadley, MI Leite, N Kissani, A Jacob… - Frontiers in …, 2020 - frontiersin.org
Neuromyelitis optica spectrum disorder (NMOSD) is an uncommon inflammatory disease of
the central nervous system, manifesting clinically as optic neuritis, myelitis, and certain brain …

Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients

A Jacob, M Matiello, BG Weinshenker… - Archives of …, 2009 - jamanetwork.com
Background Neuromyelitis optica (NMO) is the first inflammatory autoimmune demyelinating
disease of the central nervous system for which a specific antigenic target has been …

Treatment of neuromyelitis optica: review and recommendations

DJ Kimbrough, K Fujihara, A Jacob… - Multiple sclerosis and …, 2012 - Elsevier
Neuromyelitis optica (NMO) is an autoimmune demyelinating disease preferentially
targeting the optic nerves and spinal cord. Once regarded as a variant of multiple sclerosis (MS), …